Falkman , L. et al. 2024. Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors. Upsala Journal of Medical Sciences. 129, S1 (Apr. 2024), e10660. DOI:https://doi.org/10.48101/ujms.v129.10660.